1. Jiang, Tianlu, Xia, Yiwen, Li, Ying, Xu, Zekuan, Wang, Linjun. 2023. TRIM29 promotes antitumor immunity through enhancing IGF2BP1 ubiquitination and subsequent PD-L1 downregulation in gastric cancer. In Cancer letters, 581, 216510. doi:10.1016/j.canlet.2023.216510. https://pubmed.ncbi.nlm.nih.gov/38029830/
2. Huang, Wenjie, Hu, Xiaojun, He, Xiang, Cui, Chunhui, Fan, Yingfang. 2024. TRIM29 facilitates gemcitabine resistance via MEK/ERK pathway and is modulated by circRPS29/miR-770-5p axis in PDAC. In Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 74, 101079. doi:10.1016/j.drup.2024.101079. https://pubmed.ncbi.nlm.nih.gov/38518727/
3. Hsu, Che-Yuan, Yanagi, Teruki, Ujiie, Hideyuki. 2021. TRIM29 in Cutaneous Squamous Cell Carcinoma. In Frontiers in medicine, 8, 804166. doi:10.3389/fmed.2021.804166. https://pubmed.ncbi.nlm.nih.gov/34988104/
4. Qiao, Huai-Yu, Zhang, Qi, Wang, Jia-Mei, Li, Chao, Wang, Hua-Qin. 2021. TRIM29 regulates the SETBP1/SET/PP2A axis via transcription factor VEZF1 to promote progression of ovarian cancer. In Cancer letters, 529, 85-99. doi:10.1016/j.canlet.2021.12.029. https://pubmed.ncbi.nlm.nih.gov/34973391/
5. Zhang, Haiyan, Lin, Chuangxin, Zeng, Chun, Cai, Daozhang, Bai, Xiaochun. 2018. Synovial macrophage M1 polarisation exacerbates experimental osteoarthritis partially through R-spondin-2. In Annals of the rheumatic diseases, 77, 1524-1534. doi:10.1136/annrheumdis-2018-213450. https://pubmed.ncbi.nlm.nih.gov/29991473/
6. Xing, Junji, Zhang, Ao, Zhang, Hua, Zeng, Mu-Sheng, Zhang, Zhiqiang. 2017. TRIM29 promotes DNA virus infections by inhibiting innate immune response. In Nature communications, 8, 945. doi:10.1038/s41467-017-00101-w. https://pubmed.ncbi.nlm.nih.gov/29038422/
7. Sultanov, R, Mulyukina, A, Zubkova, O, Lagarkova, M, Arapidi, G. 2024. TP63-TRIM29 axis regulates enhancer methylation and chromosomal instability in prostate cancer. In Epigenetics & chromatin, 17, 6. doi:10.1186/s13072-024-00529-7. https://pubmed.ncbi.nlm.nih.gov/38481282/
8. Nagasawa, Saya, Ikeda, Kazuhiro, Shintani, Daisuke, Horie, Kuniko, Inoue, Satoshi. 2022. Identification of a Novel Oncogenic Fusion Gene SPON1-TRIM29 in Clinical Ovarian Cancer That Promotes Cell and Tumor Growth and Enhances Chemoresistance in A2780 Cells. In International journal of molecular sciences, 23, . doi:10.3390/ijms23020689. https://pubmed.ncbi.nlm.nih.gov/35054873/
9. Chen, Yuanjian, Ma, Jun, Zhang, Mingming. 2023. TRIM29 promotes the progression of colorectal cancer by suppressing EZH2 degradation. In Experimental biology and medicine (Maywood, N.J.), 248, 1527-1536. doi:10.1177/15353702231199070. https://pubmed.ncbi.nlm.nih.gov/37837384/
10. Han, Jing, Zuo, Jing, Zhang, Xue, Liu, Jiayin, Feng, Li. . TRIM29 is differentially expressed in colorectal cancers of different primary locations and affects survival by regulating tumor immunity based on retrospective study and bioinformatics analysis. In Journal of gastrointestinal oncology, 13, 1132-1151. doi:10.21037/jgo-22-365. https://pubmed.ncbi.nlm.nih.gov/35837175/
智鼠故事 
